FDA clears IND application for ART-101 for the imaging and treatment of prostate cancer June 24, 2025
FDA Approves Monjuvi (tafasitamab-cxix), Rituximab, and Lenalidomide Combination for Patients with R/R Follicular Lymphoma June 24, 2025
